×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ASRT – assertio holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ASRT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/12
04:39 pm
asrt
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements [Yahoo! Finance]
High
Report
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements [Yahoo! Finance]
1/12
04:24 pm
asrt
Assertio regains Nasdaq compliance after bid price recovery [Seeking Alpha]
High
Report
Assertio regains Nasdaq compliance after bid price recovery [Seeking Alpha]
1/12
04:15 pm
asrt
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
High
Report
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
1/11
09:26 pm
asrt
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story [Yahoo! Finance]
Low
Report
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story [Yahoo! Finance]
1/9
01:45 pm
asrt
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
Low
Report
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
1/5
07:17 am
asrt
Assertio (NASDAQ:ASRT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Assertio (NASDAQ:ASRT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/1
05:45 am
asrt
Assertio (NASDAQ:ASRT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Assertio (NASDAQ:ASRT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
12/22
04:30 pm
asrt
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split
Medium
Report
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
04:44 pm
asrt
Form 8-K Assertio Holdings, Inc. For: Jan 12
High
Report
Form 8-K Assertio Holdings, Inc. For: Jan 12
12/22
04:38 pm
asrt
Form 8-K Assertio Holdings, Inc. For: Dec 19
Medium
Report
Form 8-K Assertio Holdings, Inc. For: Dec 19
11/21
05:01 pm
asrt
Form 8-K Assertio Holdings, Inc. For: Nov 17
Low
Report
Form 8-K Assertio Holdings, Inc. For: Nov 17
11/14
06:00 pm
asrt
Form 4 Assertio Holdings, Inc. For: Nov 13 Filed by: Reisenauer Mark L
Medium
Report
Form 4 Assertio Holdings, Inc. For: Nov 13 Filed by: Reisenauer Mark L
11/12
06:00 pm
asrt
Form 4 Assertio Holdings, Inc. For: Nov 10 Filed by: Stark David Matthew
Medium
Report
Form 4 Assertio Holdings, Inc. For: Nov 10 Filed by: Stark David Matthew
11/10
04:58 pm
asrt
Form 10-Q Assertio Holdings, Inc. For: Sep 30
Low
Report
Form 10-Q Assertio Holdings, Inc. For: Sep 30
11/10
04:13 pm
asrt
Form 8-K Assertio Holdings, Inc. For: Nov 10
Low
Report
Form 8-K Assertio Holdings, Inc. For: Nov 10
11/10
04:07 pm
asrt
Form 144 Assertio Holdings, Inc. Filed by: Stark David Matthew
High
Report
Form 144 Assertio Holdings, Inc. Filed by: Stark David Matthew
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/12
Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million
48.2%
2/6 Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million 46.2%
3/11 Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024 22.4%
12/13 Hedge Funds Are Crazy About Assertio Therapeutics, Inc. (ASRT) [Yahoo! Finance News] 15.7%
3/25 Form SC TO-I/A Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc 14.9%
11/12 Form SC 13G Assertio Therapeutics, Filed by: D. E. SHAW & CO, L.P. 11.2%
8/20 Form 4 Assertio Therapeutics, For: Aug 19 Filed by: HIGGINS ARTHUR J 10.9%
2/19 Assertio Therapeutics Announces Repurchase of Approximately $188.0 Million of its Outstanding Convertible Debt 9.5%
4/24 Form 8-K Assertio Therapeutics, For: Apr 22 9.1%
10/5 How Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Affect Your Portfolio Volatility? [Yahoo! Finance News] 9.0%
2/6 Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million 46.2%
3/11 Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024 22.4%
12/13 Hedge Funds Are Crazy About Assertio Therapeutics, Inc. (ASRT) [Yahoo! Finance News] 15.7%
3/25 Form SC TO-I/A Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc 14.9%
11/12 Form SC 13G Assertio Therapeutics, Filed by: D. E. SHAW & CO, L.P. 11.2%
8/20 Form 4 Assertio Therapeutics, For: Aug 19 Filed by: HIGGINS ARTHUR J 10.9%
2/19 Assertio Therapeutics Announces Repurchase of Approximately $188.0 Million of its Outstanding Convertible Debt 9.5%
4/24 Form 8-K Assertio Therapeutics, For: Apr 22 9.1%
10/5 How Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Affect Your Portfolio Volatility? [Yahoo! Finance News] 9.0%
TOP News Decliners
8/9
Assertio Therapeutics, Inc (ASRT) Q2 2019 Earnings Call Transcript [The Motley Fool]
-45.9%
3/9 Q4/2019 12/31/2019 EPS -0.140 ZacksConsensus -0.220 ActVsEst 0.080 - Beat -30.8%
10/21 Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin -24.9%
8/20 Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference -17.4%
10/30 Ceridian HCM Holding, BJ's Wholesale Club Holdings Set to Join S&P MidCap 400; Oceaneering International, Covetrus to Join S&P SmallCap 600 -15.0%
11/6 Assertio Therapeutics, Inc. 2019 Q3 - Results - Earnings Call Presentation [Seeking Alpha] -12.2%
3/2 Assertio Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results After the Close of Markets on Monday, March 9, 2020 -11.8%
1/13 Form 8-K Assertio Therapeutics, For: Jan 10 -9.4%
4/21 Form 425 Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc -7.9%
5/9 Form 4 Assertio Therapeutics, For: May 09 Filed by: MCKEE WILLIAM -7.7%
3/9 Q4/2019 12/31/2019 EPS -0.140 ZacksConsensus -0.220 ActVsEst 0.080 - Beat -30.8%
10/21 Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin -24.9%
8/20 Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference -17.4%
10/30 Ceridian HCM Holding, BJ's Wholesale Club Holdings Set to Join S&P MidCap 400; Oceaneering International, Covetrus to Join S&P SmallCap 600 -15.0%
11/6 Assertio Therapeutics, Inc. 2019 Q3 - Results - Earnings Call Presentation [Seeking Alpha] -12.2%
3/2 Assertio Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results After the Close of Markets on Monday, March 9, 2020 -11.8%
1/13 Form 8-K Assertio Therapeutics, For: Jan 10 -9.4%
4/21 Form 425 Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc -7.9%
5/9 Form 4 Assertio Therapeutics, For: May 09 Filed by: MCKEE WILLIAM -7.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: